Know What Your Molecule Binds. Know What to Do Next.

Tissue cross-reactivity assays can tell you where your biotherapeutic binds, but not what it binds to, leaving a gap in your data.

The Membrane Proteome Array (MPA) fills this gap by precisely identifying off-target proteins. You receive actionable, human-relevant results that guide development decisions and strengthen your IND.

Read the eBook to learn how the MPA delivers specificity data your IND needs.

Contents include:

• How the MPA meets FDA guidance
• MPA deliverables: quantitative, actionable data in an IND-ready report within 4 weeks
• The MPA's track record across 100+ successful IND submissions
• Where the MPA stands in FDA's ISTAND qualification process